Autonomix Medical, Inc. (AMIX) Key Metrics
AMIX valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $5.6M
- Enterprise value
- −$2.9M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- —
- Price / book
- 2.5
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- −0.94
AMIX key metrics, FY2022–FY2026
Fiscal year ended March 31, 2026 · U.S. dollarsAMIX returns How much profit the business earns on the capital it uses.
AMIX financial health Debt, liquidity and how easily interest is covered.
AMIX efficiency & capital use Working capital cycle and where the cash goes.
AMIX returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
AMIX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
AMIX key metrics
FY2022–FY2026| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Valuation | |||||
| Share price at fiscal year-end | $8.19 | $36.75 | $1,268.40 | — | — |
| Returns & profitability | |||||
| Return on equity (ROE) | −238.9% | −145.1% | −373.0% | −152.9% | −680.2% |
| Return on assets (ROA) | −192.1% | −118.8% | −300.4% | −136.4% | −649.3% |
| Return on tangible assets | −219.9% | −116.4% | −164.0% | −230.1% | −649.3% |
| Financial health | |||||
| Total debt | — | — | $1.0M | — | — |
| Cash & short-term investments | $7.0M | $9.1M | $8.6M | $865,000 | $2.0M |
| Net debt | −$7.0M | −$9.1M | −$7.6M | −$865,000 | −$2.0M |
| Debt / equity | — | — | 0.13 | — | — |
| Debt / assets | — | — | 0.11 | — | — |
| Current ratio | 4.45 | 5.63 | 12.09 | 3.91 | 22.02 |
| Quick ratio | 4.45 | 5.63 | 12.09 | 3.91 | 22.02 |
| Interest coverage | — | -65.8 | -152.3 | — | -62.3 |
| Working capital | $5.9M | $7.9M | $8.6M | $644,000 | $2.0M |
| Invested capital | −$1.1M | −$1.0M | $22,000 | −$221,000 | −$84,511 |
| Tangible asset value | $5.9M | $8.1M | $7.6M | $644,000 | $2.0M |
| Net current asset value | $5.9M | $7.9M | $7.6M | $644,000 | $2.0M |
| Capital allocation | |||||
| Capex / depreciation | 0.83 | 0.08 | 0.23 | 0.00 | 0.00 |
| Efficiency | |||||
| Days payables outstanding | 20,926.7 | 1,164.8 | 1,498.3 | — | — |
| Payables turnover | 0.02 | 0.31 | 0.24 | — | — |
| Asset turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average payables | $688,000 | $584,000 | $332,500 | $132,311 | $91,622 |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from AMIX's annual financial statements (latest annual report filed May 27, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
AMIX valuation and financial ratios
Autonomix Medical earned a return on equity of −238.9% in fiscal 2026.
See the AMIX income statement, the AMIX chart for price history, or the AMIX stock overview for the latest quote and news.
AMIX key metrics FAQ
What is Autonomix Medical's return on equity?
Autonomix Medical's return on equity (ROE) was −238.9% in fiscal 2026: net income of -$16.7 million on average shareholders' equity of $7.0 million.
What is Autonomix Medical's current ratio?
Autonomix Medical's current ratio was 4.45 at the end of fiscal 2026: current assets were 4.45 times current liabilities.